Early trial halted for new cancer drug targeting multiple advanced cancers
NCT ID NCT05721222
Summary
This early-stage study tested a new drug called PRO1160 in 42 patients with advanced cancers that had spread or returned after previous treatments. The main goals were to find a safe dose and see if the drug could help control kidney cancer, nasopharyngeal cancer, or lymphoma. The trial was terminated early, and results are not yet publicly available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
-
City of Hope Comprehensive Cancer Center - Duarte
Duarte, California, 91010, United States
-
Cleveland Clinic - Euclid Hospital
Cleveland, Ohio, 44195, United States
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Levine Cancer Center
Charlotte, North Carolina, 28204, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Montefiore Medical Center - Montefiore Hospital
The Bronx, New York, 10467, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
-
START Mountain Cancer Center
West Valley City, Utah, 84119, United States
-
Sarah Cannon Research Institute - Nashville
Nashville, Tennessee, 37203, United States
-
The City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California, 92618, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.